@RadOncDoc_Gee Profile picture

Harriet Gee

@RadOncDoc_Gee

#RadOnc @CPMCCwestmead, #PhysicianScientist, Clin A/Prof @sydney_uni. Adjunct Research Scientist @CMRI. #radbio of #SABR/#SBRT. Usual disclaimers.

Similar User
Shalini Vinod photo

@shalinivinod13

Lucinda Morris photo

@lucindamorris23

Peppe Sasso photo

@radiopeppe

RadOncResearch photo

@HegiFiona

Prof Jarad Martin photo

@DocJarad

Lucinda Burke photo

@lucindaburke

Puma S photo

@sundap15

David Ball AO photo

@DavidDbal

Dr Noel Aherne photo

@Ozradonc

ML Yap photo

@yapml

Michael MacManus photo

@MP_MacManus

Wee Loon Ong photo

@weeloonong

Hendrick Tan photo

@Hendo_tan

Prostate_doc photo

@SukiGill01

Stephen Chin photo

@schin_au

Please complete this survey to assess attitudes and patterns of practice of SBRT in oligometastatic colorectal cancer. @ChamithaSW put it together for her PhD. The aim to improve care for these difficult to treat tumours. redcap.sydney.edu.au/surveys/?s=TTH… Do kindly share/RT. Thank you!


Harriet Gee Reposted

Congratulations to @_joesia presenting his team's work at #cogno24 yesterday about the immune response to SRS in #braincancer. Great job! @BrainCancerCtr

Tweet Image 1

Harriet Gee Reposted

Congratulations to ⁦@sandraturner49⁩ on the approval of your Hon FACR award, which is the highest honor bestowed upon a non-North American radiologist, rad onc, or med phys! ⁦@ACRCARROS1986⁩ ⁦@j_luh⁩ ⁦⁩ ⁦@RadiologyACR⁩ ⁦

Tweet Image 1
Tweet Image 2
Tweet Image 3


Thoracic Radiotherapy Improves the Survival in Patients With EGFR-Mutated Oligo-Organ Metastatic Non–Small Cell Lung Cancer Treated With Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitors: A Multicenter, Randomized, Controlled, Phase III Trial ascopubs.org/doi/10.1200/JC…



Harriet Gee Reposted

Biomarker analysis of I-SABR study by @ASeoMDPhD @ #ASTRO24 🚨Markers of immune activation & exhaustion change dynamically during tx and and follow-up ⬇️ PD-1 was seen after 1 dose of nivo ⬆️GZMB abundance +⬇️ EFS may indicate an exhausted subset of cytotoxic CD8+T + NK cells

Tweet Image 1
Tweet Image 2
Tweet Image 3
Tweet Image 4

Harriet Gee Reposted

Next in SBRT trials session at #ASTRO24 @KatieKeaneMD reports outcomes from a Ph2 study of consolidative #SABR in patients with oncogene driven #NSCLC ➡️19% risk of DF after 12 months ➡️median PFS 23.4 months ➡️No grade ≥3 adverse events ➡️Results of NORTHSTAR awaited

Tweet Image 1
Tweet Image 2
Tweet Image 3
Tweet Image 4

Harriet Gee Reposted

Presented 🚀 MISSILE 🚀 at #ASTRO2024 Combined ☢️ #SABR and 🔪 #surgery in early 🫁 #NSCLC was safe with reasonable clinical outcomes, but similar to surgery alone 🚨 Publication in RED journal here authors.elsevier.com/sd/article/S03… @drdavidpalma @DrAlexLouie @DrCorreaRO @TimkWin

Tweet Image 1
Tweet Image 2
Tweet Image 3
Tweet Image 4

Harriet Gee Reposted

Interesting study from Li et al on biomarkers in patients with brain metastases from SCLC earlier today at #ASTRO24 ⚡️incidence of BM was significantly reduced for pts with PCI treatment and FLT4 mutations; ⚡️smokers and RB1 mutations showed a significantly higher risk of BM

Tweet Image 1
Tweet Image 2
Tweet Image 3
Tweet Image 4

Harriet Gee Reposted

Congratulations @DrewMoghanaki and Team! 400/670 randomized so far.. We eagerly await the answer to a long burning question #Surgery vs #SBRT for early stage #lungcancer 👏🏼

The VALOR study team publishes its' observations evaluating the first 100 participants treated with lung SBRT through 2022. The planning guide is included in the appendix. Today, nearly 400 of 670 are randomized. #CSP2005 #radonc #ASTRO24 sciencedirect.com/science/articl…

Tweet Image 1


Congratulations Caitlin on your permanent appointment as thoracic cancer CNC #WSLHD CPMCC, welcome to the team with @AdnanNagrial

Tweet Image 1

Harriet Gee Reposted

Excited to share our review on computational advances for #singlecell and #SpatialTranscriptomics @NatRevMCB! Includes: 👉Cell plasticity 👉Spatial #ecotypes 👉#AI and foundation models Brilliantly led by @gungulati J. D'Silva with Y. Liu and @IamLinghua dlvr.it/TCBPZw


Looks like a great seminar!

If you want to hear more about how the most accurate DSB repair pathway, named homologous recombination, restricts interferon signalling and drives immediate cell death following lethal genomic damage, please join me on September 11.



Harriet Gee Reposted

Welcome more leaders #ProCan Sydney Int Conf: - Prof @annapoids, Precision Oncology in Ovarian Cancer - Prof Lois Holloway, Implementing Radiomics - A/Prof Ness Tyrrell, Improving outcomes with Multi-Omics - Prof @ZornitzaS, Rare disease diagnosis procanconference.au/speakers

Tweet Image 1

Harriet Gee Reposted

Patient communication is more effective when using "testimonials" versus "informational statements". Hence, why it's crucial to engage patients when developing informational statements. jamanetwork.com/journals/jama/…


Harriet Gee Reposted

Great to see @WestSydHealth #RadiationTherapy patients using #TargetingCancer enviro bags👏 The bags make it easy for patients to carry their belongings during treatment at cancer centres. @JulieMcCrossin #RANZCR #RadiationOncology

Tweet Image 1

Harriet Gee Reposted

See you tomorrow at 'New Horizons in ES-SCLC'. An online webinar focusing on current treatments and future therapies for Extensive Stage Small Cell Lung Cancer (ES-SCLC). Proudly sponsored by Amgen. Monday, 12 August. 6:30 PM Register Now> buff.ly/3LfLscB

Tweet Image 1

Harriet Gee Reposted

Don’t miss your opportunity to become a better #Leader! Applications are closing for #FLiRO2024 in Sydney 🏃🏼‍♀️ #rundontwalk @sandraturner49 @lucindamorris23 @Curlz1702 @RANZCRcollege @ASMIRTorg @nzimrt @ESTRO_RT @caro_acro_ca

Tweet Image 1

Harriet Gee Reposted

Our poster presenting a network meta-analysis on chemo-ICI vs ICI alone for patients with NSCLC brain metastases. Chemo-ICI has better PFS than ICI alone, but no difference in OS. @DrBenKong @Eric73363938 @inespiresilva @RadOncDoc_Gee @AdnanNagrial Nicholas Yeo @TOGAANZ #TOGA2024

Tweet Image 1

Harriet Gee Reposted

🧠⚡️🫁☢️New in @JCO_ASCO from @pike_lab @Chad_Rusthoven: The addition of up-front #radiation #SRS to CNS-penetrant #TKI ⬆️time-to-CNS progression & local control (but not OS) in pts with brain mets from #EGFR #ALK-driven #NSCLC #lungcancer. #lcsm #radonc ascopubs.org/doi/10.1200/JC…

Tweet Image 1

Loading...

Something went wrong.


Something went wrong.